WO2003013587A1 - Compositions pour l'occlusion vasculaire - Google Patents

Compositions pour l'occlusion vasculaire Download PDF

Info

Publication number
WO2003013587A1
WO2003013587A1 PCT/JP2002/007894 JP0207894W WO03013587A1 WO 2003013587 A1 WO2003013587 A1 WO 2003013587A1 JP 0207894 W JP0207894 W JP 0207894W WO 03013587 A1 WO03013587 A1 WO 03013587A1
Authority
WO
WIPO (PCT)
Prior art keywords
growth factor
cell growth
composition
aneurysm
composition according
Prior art date
Application number
PCT/JP2002/007894
Other languages
English (en)
Japanese (ja)
Inventor
Yasuhiko Tabata
Susumu Miyamoto
Keisuke Yamada
Original Assignee
Yasuhiko Tabata
Susumu Miyamoto
Keisuke Yamada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yasuhiko Tabata, Susumu Miyamoto, Keisuke Yamada filed Critical Yasuhiko Tabata
Publication of WO2003013587A1 publication Critical patent/WO2003013587A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214—Coils or wires
    • A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne l'obtention de compositions destinées à l'occlusion vasculaire utiles pour traiter l'anévrisme, lesquelles contiennent un élément fibreux, un élément capable de libérer graduellement un facteur de croissance cellulaire ainsi que le facteur de croissance cellulaire.
PCT/JP2002/007894 2001-08-03 2002-08-02 Compositions pour l'occlusion vasculaire WO2003013587A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-236422 2001-08-03
JP2001236422A JP2003048841A (ja) 2001-08-03 2001-08-03 血管閉塞用組成物

Publications (1)

Publication Number Publication Date
WO2003013587A1 true WO2003013587A1 (fr) 2003-02-20

Family

ID=19067695

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/007894 WO2003013587A1 (fr) 2001-08-03 2002-08-02 Compositions pour l'occlusion vasculaire

Country Status (2)

Country Link
JP (1) JP2003048841A (fr)
WO (1) WO2003013587A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011526510A (ja) * 2008-07-04 2011-10-13 フジフィルム・マニュファクチュアリング・ヨーロッパ・ベスローテン・フエンノートシャップ 医療用デバイスのコーティング方法
WO2013112491A1 (fr) * 2012-01-23 2013-08-01 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels ajustables et procédés de préparation associés
WO2024034610A1 (fr) * 2022-08-08 2024-02-15 三菱ケミカル株式会社 Hydrogel congelé et décongelé, son procédé de production, dispositif médical ophtalmique et lentille de contact

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006884A1 (fr) * 1991-10-02 1993-04-15 Target Therapeutics, Inc. Fil metallique helicoïdal de vasoocclusion auquel est rattache au moins un element fibreux
WO1994010936A1 (fr) * 1992-11-18 1994-05-26 Target Therapeutics, Inc. Dispositifs d'embolie ultrasouples et procede d'utilisation
WO1994015534A1 (fr) * 1993-01-15 1994-07-21 Target Therapeutics, Inc. Dispositif de vaso-occlusion contenant des fibres opaques aux rayons x
EP0739608A1 (fr) * 1995-04-28 1996-10-30 Target Therapeutics, Inc. Dispositifs vasoocclusives avec d'une fibre polymère fixée par chaud
WO2001030411A1 (fr) * 1999-10-26 2001-05-03 Kaken Pharmaceutical Co., Ltd. Materiau de traitement d'embolie vasculaire a base d'hydrogel et therapie correspondante

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006884A1 (fr) * 1991-10-02 1993-04-15 Target Therapeutics, Inc. Fil metallique helicoïdal de vasoocclusion auquel est rattache au moins un element fibreux
WO1994010936A1 (fr) * 1992-11-18 1994-05-26 Target Therapeutics, Inc. Dispositifs d'embolie ultrasouples et procede d'utilisation
WO1994015534A1 (fr) * 1993-01-15 1994-07-21 Target Therapeutics, Inc. Dispositif de vaso-occlusion contenant des fibres opaques aux rayons x
EP0739608A1 (fr) * 1995-04-28 1996-10-30 Target Therapeutics, Inc. Dispositifs vasoocclusives avec d'une fibre polymère fixée par chaud
WO2001030411A1 (fr) * 1999-10-26 2001-05-03 Kaken Pharmaceutical Co., Ltd. Materiau de traitement d'embolie vasculaire a base d'hydrogel et therapie correspondante

Also Published As

Publication number Publication date
JP2003048841A (ja) 2003-02-21

Similar Documents

Publication Publication Date Title
US5935145A (en) Vaso-occlusive device with attached polymeric materials
EP1142535B1 (fr) Dispositif d'embolisation
JP4723584B2 (ja) 生物学的、生物分解性若しくは合成重合体又は繊維が巻き付けられた体腔を閉塞するための金属製コイル
US6187024B1 (en) Bioactive coating for vaso-occlusive devices
US6299627B1 (en) Water-soluble coating for bioactive vasoocclusive devices
JP4236871B2 (ja) 血小板癒着力を向上させた塞栓コイル
US20030004568A1 (en) Coated combination vaso-occlusive device
US20020082620A1 (en) Bioactive materials for aneurysm repair
US20030093111A1 (en) Device for vaso-occlusion and interventional therapy
US20040024394A1 (en) Absorbable implantable vaso-occlusive member
US20020087184A1 (en) Water-soluble coating for bioactive devices
US20050283182A1 (en) Systems and methods for intraluminal delivery of occlusive elements
WO2003013587A1 (fr) Compositions pour l'occlusion vasculaire
Brohim et al. Development of independent vessel security after ligation with absorbable sutures or clips
JP2004261218A (ja) 血管塞栓用組成物
WO1999047047A1 (fr) Modification biologique de dispositifs pour occlusion vasculaire

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS KE KG KR KZ LC LR LS LT LU LV MA MD MG MK MN MX MZ NO NZ OM PH PL PT RO RU SE SG SI SK SL TJ TM TN TR TT TZ UG US UZ VN YU ZA ZM

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase